PriceTargets.com logo

Hippo - HIPO Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $28.00
  • Forecasted Upside: 6.50%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$26.29 As of 12/20/2024 06:16 PM ET
▲ +1.03 (4.08%)

This chart shows the closing price for HIPO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hippo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HIPO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HIPO

Analyst Price Target is $28.00
▲ +6.50% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Hippo in the last 3 months. The average price target is $28.00, with a high forecast of $35.00 and a low forecast of $21.00. The average price target represents a 6.50% upside from the last price of $26.29.

This chart shows the closing price for HIPO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 polled investment analysts is to moderate buy stock in Hippo. This rating has held steady since September 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/22/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $35.00
10/9/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$29.00 ➝ $28.00
8/19/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$20.00 ➝ $21.00
7/22/2024Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$22.00 ➝ $20.00
5/10/2024Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$21.00 ➝ $22.00
4/15/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$25.00
11/15/2023Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$19.00 ➝ $16.00
11/3/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$10.00 ➝ $11.00
10/13/2023JMP SecuritiesLower TargetMarket Outperform ➝ Market Outperform$50.00 ➝ $25.00
8/17/2023Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$23.00 ➝ $19.00
8/11/2023William BlairInitiated CoverageMarket Perform
8/9/2023JMP SecuritiesLower TargetMarket Outperform ➝ Market Outperform$70.00 ➝ $50.00
3/6/2023Keefe, Bruyette & WoodsBoost TargetOutperform$24.00 ➝ $25.00
1/9/2023The Goldman Sachs GroupLower TargetNeutral$28.00 ➝ $23.00
11/22/2022Morgan StanleyLower TargetOverweight$51.50 ➝ $17.50
11/17/2022Keefe, Bruyette & WoodsInitiated CoverageOutperform$24.00
10/18/2022JMP SecuritiesLower TargetMarket Outperform$100.00 ➝ $70.00
10/6/2022The Goldman Sachs GroupLower TargetNeutral$75.00 ➝ $28.00
9/30/2022Morgan StanleyBoost TargetOverweight$51.50
8/19/2022Morgan StanleyLower TargetOverweight$94.00 ➝ $51.50
4/5/2022The Goldman Sachs GroupLower TargetNeutral$135.00 ➝ $75.00
3/15/2022Morgan StanleyLower TargetOverweight$115.00 ➝ $94.00
2/9/2022JMP SecuritiesInitiated CoverageOutperform$100.00
12/21/2021Morgan StanleyInitiated CoverageOverweight$115.00
11/18/2021Jefferies Financial GroupInitiated CoverageBuy$200.00
10/12/2021The Goldman Sachs GroupInitiated CoverageNeutral$135.00
(Data available from 12/22/2019 forward)

News Sentiment Rating

0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 28 positive mentions
  • 9 negative mentions
  • 12 very negative mentions
Mentions as of
5/25/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
7/24/2024
  • 13 very positive mentions
  • 40 positive mentions
  • 6 negative mentions
  • 5 very negative mentions
Mentions as of
8/23/2024
  • 5 very positive mentions
  • 50 positive mentions
  • 10 negative mentions
  • 7 very negative mentions
Mentions as of
9/22/2024
  • 12 very positive mentions
  • 50 positive mentions
  • 6 negative mentions
  • 6 very negative mentions
Mentions as of
10/22/2024
  • 15 very positive mentions
  • 67 positive mentions
  • 7 negative mentions
  • 3 very negative mentions
Mentions as of
11/21/2024
  • 7 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 7 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 7 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 7 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Hippo logo
Hippo Holdings Inc. provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products. The company distributes insurance products and services through its technology platform and website, as well as operates licensed insurance agencies. Hippo Holdings Inc. is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $26.29
Low: $24.64
High: $26.74

50 Day Range

MA: $25.85
Low: $18.27
High: $33.96

52 Week Range

Now: $26.29
Low: $7.75
High: $34.24

Volume

236,433 shs

Average Volume

161,060 shs

Market Capitalization

$640.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Frequently Asked Questions

What sell-side analysts currently cover shares of Hippo?

The following sell-side analysts have issued research reports on Hippo in the last year: Jefferies Financial Group Inc., JMP Securities, and Keefe, Bruyette & Woods.
View the latest analyst ratings for HIPO.

What is the current price target for Hippo?

0 Wall Street analysts have set twelve-month price targets for Hippo in the last year. Their average twelve-month price target is $28.00, suggesting a possible upside of 6.5%. JMP Securities has the highest price target set, predicting HIPO will reach $35.00 in the next twelve months. Keefe, Bruyette & Woods has the lowest price target set, forecasting a price of $21.00 for Hippo in the next year.
View the latest price targets for HIPO.

What is the current consensus analyst rating for Hippo?

Hippo currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for HIPO.

What other companies compete with Hippo?

Other companies that are similar to Hippo include SiriusPoint, Trupanion, Fidelis Insurance, Alignment Healthcare and Skyward Specialty Insurance Group. Learn More about companies similar to Hippo.

How do I contact Hippo's investor relations team?

Hippo's physical mailing address is 215 PARK AVENUE FLOOR 11, NEW YORK NY, 10003. The company's listed phone number is 650-294-8463 and its investor relations email address is [email protected]. The official website for Hippo is www.hippo.com. Learn More about contacing Hippo investor relations.